Vistagen TherapeuticsVTGN
13F holders, Q1 2024 (March 31)41holders
3famous investors
$5.25avg. 13F price*
At the end of Q1 2024, 41 institutions reported holding Vistagen Therapeutics Inc. (VTGN) in their 13F filings. The largest holders were BVF Inc. ($10.6M), Great Point Partners LLC ($9.8M) and Vanguard Group Inc. ($9.5M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Vistagen Therapeutics Inc.
- CUSIP
- 92840H400
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $2.7M |
| Exits | 11 | $1.1M |
Ownership 41 holders
| BVF Inc. | 0.29% | No change | 2,000,000 | $10.6M |
| Great Point Partners LLC | 1.53% | No change | 1,858,735 | $9.8M |
| Vanguard Group Inc. | 0.00% | Reduce -2.3% | 1,793,166 | $9.5M |
| Stempoint Capital LP | 2.48% | Add +3.3% | 1,848,582 | $9.3M |
| Commodore Capital LP | 0.56% | No change | 1,575,000 | $8.3M |
| Nantahala Capital Management, LLC | 0.79% | Reduce -16.5% | 1,517,696 | $8.0M |
| Sphera Funds Management LTD. | 0.69% | No change | 808,550 | $4.3M |
| Citadel Advisors | 0.00% | Add +0.1% | 743,920 | $3.9M |
| Armistice Capital, LLC | 0.05% | Reduce -23.9% | 364,000 | $1.9M |
| BlackRock Inc. | 0.00% | Add +0.5% | 348,438 | $1.8M |
| Susquehanna International Group, LLP | 0.00% | New | 288,885 | $1.5M |
| Geode Capital Management, LLC | 0.00% | Add +1.8% | 279,482 | $1.5M |
| Goldman Sachs Group Inc. | 0.00% | Add +1.4% | 166,164 | $877K |
| BML Capital Management, LLC | 0.53% | No change | 150,000 | $792K |
| Two Sigma Investments, LP | 0.00% | Reduce -24.8% | 144,386 | $762K |
| Renaissance Technologies | 0.00% | New | 109,800 | $580K |
| ADAR1 Capital Management, LLC | 0.13% | Reduce -63.4% | 89,938 | $475K |
| State Street Corp. | 0.00% | Add +69.1% | 83,708 | $442K |
| AdvisorShares Investments LLC | 0.07% | Add +32.7% | 72,071 | $381K |
| Blair William & Co. | 0.00% | Reduce -22.2% | 68,466 | $362K |
| Northern Trust Corp. | 0.00% | Add +2.4% | 50,018 | $264K |
| Millennium Management | 0.00% | New | 36,498 | $193K |
| Citigroup Inc. | 0.00% | Reduce -40.2% | 34,906 | $184K |
| Acadian Asset Management LLC | 0.00% | New | 32,291 | $169K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 23,302 | $123K |
| Barclays PLC | 0.00% | No change | 23,077 | $122K |
| Morgan Stanley | 0.00% | Add +9.6% | 21,459 | $113K |
| American Century Companies Inc. | 0.00% | New | 20,331 | $107K |
| ExodusPoint Capital Management, LP | 0.00% | New | 18,443 | $97K |
| Osaic Holdings, Inc. | 0.00% | Add +11.4% | 11,660 | $62K |
| Bank of America Corp. | 0.00% | Reduce -47.8% | 10,129 | $53K |
| GPS Wealth Strategies Group, LLC | 0.01% | No change | 8,441 | $45K |
| UBS Group AG | 0.00% | Add +3947.9% | 4,736 | $25K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -63.0% | 3,444 | $18K |
| Cwm, LLC | 0.00% | Reduce -1.4% | 2,416 | $13K |
| Bfsg, LLC | 0.00% | No change | 1,000 | $5K |
| Wells Fargo & Company | 0.00% | Add +1.4% | 211 | $1K |
| Farther Finance Advisors, LLC | 0.00% | New | 81 | $437 |
| Jones Financial Companies LLLP | 0.00% | No change | 80 | $422 |
| Fairman Group, LLC | 0.00% | No change | 29 | $153 |
| JPMorgan Chase & Co. | 0.00% | No change | 16 | $84 |
"% of holder's portfolio" is VTGN's weight in each manager's 13F, not the share of Vistagen Therapeutics Inc. the manager owns.